Methyl Hesperidin Emerges as a Promising Health Supplement and Pharmaceutical Ingredient
In recent years, methyl hesperidin, a natural bioflavonoid derived from citrus fruits, has garnered significant attention from the health supplement and pharmaceutical industries for its multifaceted benefits. As scientific research delves deeper into its pharmacological properties, methyl hesperidin is poised to revolutionize various healthcare applications.
Methyl hesperidin, also known as methyl orange peel glycoside, is a water-soluble mixture of dihydroflavone-type methyl hesperidin compounds. With a molecular weight of approximately 626, this compound boasts vitamin P-like efficacy, enhancing the actions of vitamin C and exhibiting potent antiviral and antibacterial properties. Large doses of methyl hesperidin have been found to inhibit the reproduction of influenza viruses, offering a natural defense against seasonal flu outbreaks.
Furthermore, methyl hesperidin inhibits tyrosinase, an enzyme responsible for skin darkening, making it an effective ingredient in skin care products for treating blemishes, freckles, and other pigmentation issues. Its ability to maintain normal vascular permeability, improve capillary resistance, and strengthen capillary elasticity and toughness, is invaluable in preventing and treating conditions such as nosebleeds, retinal hemorrhages, gum bleeding, and other capillary-related bleeding disorders.
According to industry reports, the global market for methyl hesperidin and its precursor, hesperidin, is experiencing steady growth. In 2023, the global hesperidin market reached US740million,withanestimatedcompoundannualgrowthrate(CAGR)of10.531.315 billion by 2029. This robust growth is fueled by the increasing demand for natural health supplements and pharmaceuticals with proven efficacy.
China, a leading producer of citrus fruits, holds a significant position in the global methyl hesperidin market. Local enterprises such as Chengdu Shuxi Pharmaceutical, Hunan Yuantong Pharmaceutical, and Sichuan Xieli Pharmaceutical are driving innovation and production capabilities, ensuring high-quality methyl hesperidin is readily available for global markets.
Methyl hesperidin's versatility extends beyond traditional health applications. It is incorporated into skin care products for anti-aging and brightening effects, oral health products to prevent tooth discoloration and gum bleeding, and even as a functional food additive, providing nutritional support and colorant properties. The inclusion of 0.1% methyl hesperidin in toothpaste has been shown to inhibit plaque formation, eliminate bad breath, and even offer protection against influenza viruses.
Research into methyl hesperidin's potential as a therapeutic agent for cardiovascular diseases, including hypertension, atherosclerosis, and cerebral hemorrhage, is ongoing. Early findings suggest that this natural compound could play a crucial role in preventive medicine, reducing the reliance on synthetic drugs with potential side effects.
Looking ahead, the methyl hesperidin industry is poised for further expansion, driven by continuous advancements in extraction and purification technologies, increased consumer awareness of natural health products, and growing global demand for multifunctional ingredients. With the support of government policies promoting natural health products and sustained investment in research and development, the future of methyl hesperidin as a health supplement and pharmaceutical ingredient looks bright.
Contact:James Yang
Tel/WhatsApp:+8619992603115
WeChat:19992603115
Email:sales@xabcbiotech.com